Columbus-based Redi Health raises $14 million for digital pharma support

Redi Health, a Columbus-based provider of digital pharma support to patients with chronic health conditions, has raised $14 million in a Series B round.

Redi says the funding underscores its success in reaching millions of patients across the country and will be used to solidify its position as a leader in the digital health space.

The Columbus startup bridges the gap between consumer technology and clinical health and support, engaging patients with medication reminders, symptom management, diet and nutrition advice, weight and activity tracking, and health literacy and education. 

The round was led by Blue Heron Capital, with participation from North Coast Ventures and existing investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. 

What it means for Ohio

Ohio is a global leader in healthcare and home to a number of top ranked hospital systems such as the Cleveland Clinic (ranked #2 in the world) and Cincinnati Children’s Hospital (ranked #1 in the nation for children’s hospitals).

Redi Health’s raise comes amid a wave of positive developments in Ohio’s healthcare and biotech space for startups.

A few recent headlines:

• Amgen opened its “most technologically advanced” facility in Ohio

• Enable Injections is expanding manufacturing operations with a new facility in the Cincinnati suburb of Springdale

• Case Western Reserve spinoff AlensiaXR raised $3 million to accelerate development of its 3D holograms for medical students

• Ohio State Spinoff Basking Biosciences raises $55 million to test stroke treatment

• Cleveland’s SPR Therapeutics raises $85M for non-opioid pain treatment option

• Cleveland Diagnostics secures $75 million funding to advance early-stage cancer detection

• Clarametyx Biosciences, a Columbus-based BioTech, raised a $33 million Series A

• Cleveland Clinic and Canon joined forces to create an imaging research center

• Augment Therapy, Cleveland-based HealthTech startup, raised a $2.7 million seed plus round

• University Hospitals launched the Haslam Sports Innovation Center in Cleveland with a $20 million donation

• Forge Biologics, a Columbus startup, announced $620 million acquisition

For more information on Redi Health, visit redi.health.

What they’re saying

"We are at a pivotal moment in healthcare, where technology integration can significantly enhance patient care and outcomes. This new financing is a testament to the hard work of our team and the support of our investors. With Blue Heron Capital's backing, we are poised to bring new products to market, expand our reach, and continue to innovate at the intersection of technology and healthcare. Our goal is to make comprehensive, patient-centered care accessible to millions more across the country."

- Luke Buchanan, Co-Founder, and CEO of Redi Health 

"Redi Health's innovative approach to digital healthcare sets them apart in today's rapidly evolving industry. We are impressed by Redi Health's commitment to improving patient outcomes and their ability to scale effectively."

- Jim Clair, Blue Heron Capital OA Collaborative member and a new member of Redi Health's Board of Directors

"Our investment in Redi Health reflects our confidence in the vision of the leadership team. The digital health sector presents a tremendous opportunity for innovation, and Redi Health is at the forefront of this transformation. We look forward to being a part of the company as they continue to innovate and positively impact the lives of patients nationwide."

- Gordon Crenshaw, Partner at Blue Heron Capital